로딩 중…
지수 로딩 중…
Macrogen, Inc.
038290· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩11,760+0.60%
2026-09-18
Financials
Valuation Metrics
Macrogen, Inc.'s Market Cap is ₩1275B. At end of 2025 it was ₩1829B. Ranked #1126 of 2,421 in KR market (top 47%), #592 of 1,640 on KOSDAQ (top 36%), #128 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 55%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 127.49B KRW | KR#1,126/2,421 Sec#128/231 |
| Revenue | 201.62B KRW | KR#1,032/2,421 Sec#60/231 |
| Net Income | 8.71B KRW | KR#1,017/2,421 Sec#62/231 |
| Total Assets | 370.47B KRW | KR#912/2,421 Sec#55/231 |
| Net Assets | 171.22B KRW | KR#1,048/2,421 Sec#73/231 |
| Employees | 529 | KR#468/2,421 Sec#38/231 |
| Value | ||
| P/E | 14.64x | KR#1,028/2,421 Sec#60/231 |
| P/B | 0.74x | KR#1,182/2,421 Sec#70/231 |
| PEG | 0.00x | KR#50/2,421 Sec#3/231 |
| P/S | 0.63x | KR#1,080/2,421 Sec#51/231 |
| EV/EBITDA | 34.38x | KR#1,248/2,421 Sec#78/231 |
| FCF Yield | -10.15% | KR—/2,421 Sec—/231 |
| Profitability | ||
| ROE | 5.09% | KR#1,090/2,421 Sec#75/231 |
| ROA | 2.35% | KR#1,150/2,421 Sec#85/231 |
| Op. Margin | 2.45% | KR#1,322/2,421 Sec#94/231 |
| Revenue Growth | 23.00% | KR#500/2,421 Sec#47/231 |
| Earnings Growth | 4373.90% | KR#18/2,421 Sec#3/231 |
| Financial Health | ||
| Debt Ratio | 116.38% | KR#1,692/2,421 Sec#193/231 |
| Total Debt | 98.93B KRW | KR#731/2,421 Sec#46/231 |
| FCF | -12.94B KRW | KR#1,782/2,421 Sec#159/231 |
| Cash | 56.45B KRW | KR#689/2,421 Sec#38/231 |
| Current Ratio | 0.85x | KR#1,892/2,421 Sec#184/231 |
| Net Debt/EBITDA | 8.59x | KR#1,170/2,421 Sec#85/231 |
| Dividend | ||
| Div. Yield | 4.17% | KR#397/2,421 Sec#13/231 |
| Div. Growth | 66.67% | KR#179/2,421 Sec#6/231 |
| Performance | ||
| 1Y Return | -26.41% | KR#1,448/2,421 Sec#108/231 |
| 1M Return | -2.65% | KR#1,544/2,421 Sec#122/231 |
| From 52W High | -43.73% | KR#1,091/2,421 Sec#78/231 |
| 1Y MDD | -45.18% | KR#779/2,421 Sec#63/231 |
| Trading | ||
| Volume | 7,317 shares | KR#2,029/2,421 Sec#193/231 |
| Trading Value | 86.0M KRW | KR#1,623/2,421 Sec#159/231 |
| Foreign Own. | 4.13% | KR#1,018/2,421 Sec#92/231 |
| Per Share | ||
| EPS | 803 KRW | KR#806/2,421 Sec#57/231 |
| BPS | 15,793 KRW | KR#665/2,421 Sec#43/231 |
Company Info
동사는 1997년 설립된 정밀의학 생명공학기업으로 2000년 코스닥에 상장되었으며 2023년 유럽법인이 스위스, 일본 법인을 설립함. 유전체 분석, Oligo합성, Microarray 분석, 유전자변형 마우스 제작 등 유전체 서비스 제공하며 CES, NGS 두 분야로 사업 운영하고 있음. 주요 도시 지놈센터 거점을 통해 '$100 DNA 몸 설계도' 제공을 목표로 정밀 맞춤의학 실현에 앞장서고 있음. 마크로젠는 1997년에 설립되었으며 서울특별시 강남구에 본사를 두고 있습니다.